Research grants on which Hyun Je Kim serves as principal investigator (including co-PI and subproject PI). Updated October 2026.

Current

• 2026.09–2027.08  Evaluation of CAR-Treg Therapeutic Efficacy in Hidradenitis Suppurativa Using an NSG Mouse Model Established with DLL4-Expressing Cell Lines. Seoul National University Hospital

• 2026.08–2027.07  Identification of key disease-driving cell populations and precision-medicine targets in immune diseases through single-cell and spatial transcriptomic multi-omics analysis of Korean patients. Seoul National University College of Medicine

• 2026.07–2028.12  Development of digital genetic diagnostic technology for early diagnosis of pediatric rheumatic rare diseases based on a Korea–UK international joint cohort. Ministry of Health and Welfare

• 2026.04–2028.12  Development of a Central Dogma-based hierarchical multi-view, multimodal foundation model for precision diagnosis of intractable immune diseases. Ministry of Science and ICT

• 2024.04–2027.03  Regulatory T cell phenotype profiling in psoriasis. Seoul National University Hospital

• 2025.12–2026.12  Spatial transcriptomics-based characterization of the peritumoral stromal reaction in lung metastases by primary tumor origin and discovery of therapeutic targets. Daewoong Foundation

• 2024.11–2029.04  Rapid development of MLT, a new modality therapeutics for cold tumors, by target discovery based on spatial transcriptomics and in silico/organoid validation. Ministry of Health and Welfare

• 2024.07–2026.12  Development of an AI-based target discovery platform using high-resolution multi-omics data for hidradenitis suppurativa. Ministry of Health and Welfare

• 2022.04–2027.12  Establishing a meta-platform for discovering molecular targets for disease treatment by building a multi-layered immune disease single-cell map. National Research Foundation of Korea

Completed

• 2023.07–2026.06  Identifying critical factors in human regulatory T cell development using single-cell and spatial transcriptomic profiling. Seoul National University

• 2025.04–2026.03  Discovery of intralesional cellular networks and novel regulators through multi-omics analysis of human aortic aneurysm. Seoul National University Hospital

• 2024.05–2025.04  Investigations on the novel therapeutic targets in pancreatic cancer. Seoul National University Cancer Research Institute

• 2023.12–2025.12  AI-based integration of multi-omics data for early detection of antibody-mediated rejection in kidney transplantation. Seoul National University

• 2023.08–2024.07  Discovery of specific biomarkers for diagnosis and treatment of lymphedema using single nucleus RNA-seq of stromal vascular fraction cells. Seoul National University

• 2023.01–2025.12  Investigating the pathology and reversibility of right heart dysfunction using spatial transcriptomics and functional imaging studies in tetralogy of Fallot patients. Child Cancer and Rare Disease Project

• 2023.05–2024.04  Establishment of high resolution molecular atlas of skin cancers from Korean patients. Seoul National University

• 2023.01–2025.12  Investigating the pathology and reversibility of right heart dysfunction using spatial transcriptomics and functional imaging studies in tetralogy of Fallot patients. Seoul National University Hospital

• 2023.01–2023.12  Establishment of high resolution atlas of skin tumor microenvironment through scRNAseq. Seoul National University Hospital

• 2022.10–2023.09  Study on single-immune cell transcriptome and epigenome in COVID19 vaccinated individuals. Seoul National University

• 2022.04–2023.03  COVID19 vaccinated patient project. Korea Disease Control and Prevention Agency

• 2021.03–2023.02  Multidimensional analysis of regulatory T cells in Korean patients with atopic dermatitis using CyTOF and single-cell transcriptomics. National Research Foundation of Korea

• 2020.03–2023.02  Basic Science Research Program. National Research Foundation of Korea

Industry-sponsored collaborations: available upon request.